Naoki Manda

A Randomized Controlled Trial Comparing the Effects of Sitagliptin and Glimepiride on Endothelial Function and Metabolic Parameters: Sapporo Athero-Incretin Study 1 (SAIS1)

Hiroshi Nomoto, Hideaki Miyoshi, Tomoo Furumoto et al. · PLoS ONE · 2016 · 57 citations · Full text

Medicine, Endocrinology, Pharmacology +12

A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2)

Hiroshi Nomoto, Hideaki Miyoshi, Tomoo Furumoto et al. · PLoS ONE · 2015 · 53 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial

Takahiro Takase, Akinobu Nakamura, Hiroshi Nomoto et al. · Journal of Diabetes Investigation · 2018 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)

Naoyuki Kitao, Hideaki Miyoshi, Tomoo Furumoto et al. · Cardiovascular Diabetology · 2017 · 41 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of Aspirin on Cancer Chemoprevention in Japanese Patients With Type 2 Diabetes: 10-Year Observational Follow-up of a Randomized Controlled Trial

Sadanori Okada, Takeshi Morimoto, Hisao Ogawa et al. · Diabetes Care · 2018 · 24 citations

Medicine, Pharmacology, Pharmacotherapy +9